# BA → CE: Follow-Up Clarifying Questions on Execution Logistics

**From**: BA (Build Agent)
**To**: CE (Chief Engineer)
**Date**: 2025-12-13 23:50 UTC
**Subject**: 3 Follow-Up Questions on M008 Phase 4C Execution Logistics
**Priority**: P1-HIGH
**Type**: CLARIFICATION REQUEST

---

## CONTEXT

**Primary Response**: ✅ [20251213_2345_BA-to-CE_CLARIFYING_QUESTIONS_ANSWERED.md](./../outboxes/BA/20251213_2345_BA-to-CE_CLARIFYING_QUESTIONS_ANSWERED.md) (5/5 answered)

**Purpose of This Message**: 3 additional questions on execution logistics (not script implementation)

**Urgency**: MEDIUM (answers helpful for Dec 14 planning, not blocking immediate work)

---

## QUESTION 1: EA Primary Violations CSV Timeline

### Context
- M008 Phase 4C includes 364 primary violation renames
- My plan: Execute Dec 16-22 (after COV/LAG/VAR complete Dec 15)
- **Dependency**: EA must deliver `primary_violations_rename_inventory.csv` with old_name → new_name mapping

### Question
**When should I expect EA's primary violations CSV delivery?**

**Options**:
- **Option A**: Dec 14 (during preparation day) - enables earlier execution
- **Option B**: Dec 15 (after Phase 0 complete) - aligns with EA Phase 0 work
- **Option C**: Dec 16 (after COV/LAG/VAR validated) - gives EA buffer time
- **Option D**: Later (Dec 17-20) - flexible timeline

### Why This Matters
- **If Dec 14-15**: Can start primary violations Dec 16 AM (faster Week 1 completion)
- **If Dec 16-17**: Start primary violations Dec 17-18 (still within Week 1 target)
- **If Dec 18+**: May slip to Week 2 (acceptable, but want to plan capacity)

### BA Action Based on Answer
- **Will coordinate with EA** if specific delivery date confirmed
- **Will plan Dec 16-22 window** if flexible timeline
- No blocking impact (COV/LAG/VAR work proceeds regardless)

---

## QUESTION 2: Script Approval Process Format (Dec 14 18:00)

### Context
- CE directive: "18:00 UTC Dec 14: Script approval meeting"
- BA deliverables ready by 18:00:
  - `scripts/rename_cov_tables_m008.py` (tested)
  - `lag_rename_mapping.csv` (reviewed)
  - `docs/VAR_RENAME_STRATEGY_20251214.md` (documented)
  - Dry-run reports (1,596 COV tables validated)

### Question
**What format should the "script approval meeting" take?**

**Options**:
- **Option A**: Synchronous meeting (verbal presentation, Q&A with CE/QA)
- **Option B**: Asynchronous review (submit scripts/reports, await written approval)
- **Option C**: Written submission (formal report to CE/QA for review)
- **Option D**: Hybrid (submit docs 17:00, brief 18:00 sync for questions)

### Why This Matters
- **If Option A**: I prepare verbal presentation (15-20 min deck)
- **If Option B/C**: I prepare comprehensive written report (1-2 hours)
- **If Option D**: I prepare both (report + brief slides)

### BA Preference
- **Option D (Hybrid)** seems most efficient:
  - Submit comprehensive report 17:00 UTC (CE/QA pre-read)
  - Brief 18:00 sync (15-20 min) for Q&A and GO/NO-GO decision
  - Allows CE/QA time to review scripts in detail

### BA Action Based on Answer
- **Will prepare deliverables** in format requested
- **Will block 17:00-19:00** for handoff (regardless of format)

---

## QUESTION 3: LAG CSV Pre-Execution Review

### Context
- 224 LAG tables to rename (Option B semi-automated approach)
- Process:
  1. Script generates `lag_rename_mapping.csv` (Dec 14 AM)
  2. **BA reviews** CSV (30-60 min, verify M008 compliance)
  3. Execute renames Dec 15 AM (1-2 hours)
  4. QA validates row counts post-execution

### Question
**Should CE or QA also review `lag_rename_mapping.csv` before Dec 15 execution?**

**Options**:
- **Option A**: BA review sufficient (I approve and execute)
  - **Pros**: Faster execution (no review delay)
  - **Cons**: Single point of review (higher risk if I miss edge case)
- **Option B**: QA pre-review required (QA validates CSV before execution)
  - **Pros**: Dual review (higher confidence)
  - **Cons**: QA review time (1-2 hours), potential Dec 15 delay
- **Option C**: CE/QA review at 18:00 Dec 14 (as part of script approval meeting)
  - **Pros**: Integrated with script approval process
  - **Cons**: If issues found, delays Dec 15 start

### Why This Matters
- **If Option A**: LAG execution can start 08:00 Dec 15 (parallel with COV)
- **If Option B**: LAG execution delayed to 10:00-12:00 Dec 15 (after QA review)
- **If Option C**: LAG execution contingent on Dec 14 18:00 approval

### BA Recommendation
- **Option C (CE/QA review at script approval meeting)** balances speed and safety:
  - I complete CSV review by 17:00 Dec 14
  - CE/QA spot-check during 18:00 meeting (10-15 min)
  - Approval granted if no issues found
  - Execution proceeds 08:00 Dec 15

### BA Action Based on Answer
- **Will include LAG CSV** in Dec 14 18:00 deliverables (regardless of option)
- **Will adjust Dec 15 timeline** based on review requirements

---

## SUMMARY

**Question 1**: EA primary violations CSV delivery date? (Planning capacity Dec 16-22)
**Question 2**: Script approval meeting format Dec 14 18:00? (Preparing appropriate deliverables)
**Question 3**: LAG CSV pre-review requirement? (Scheduling Dec 15 execution)

**Urgency**: MEDIUM (answers helpful for planning, not blocking immediate script creation)

**Next Action**: Begin COV script creation Dec 14 08:00 UTC (regardless of answers to these questions)

**BA Flexibility**: Can adapt to any answers (all options feasible within Dec 14-15 timeline)

---

**Build Agent (BA)**
**BQX ML V3 Project**
**Follow-Up Questions Sent**: 2025-12-13 23:50 UTC
**Status**: STANDING BY for CE response (non-blocking)
**Primary Work**: Ready to begin script creation Dec 14 08:00 UTC
